STOCK TITAN

[424B2] Morgan Stanley Prospectus Supplement

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
424B2
Rhea-AI Filing Summary

Morgan Stanley Finance LLC (Series A Global MTN Program) has filed Pricing Supplement No. 9,145 for $5.07 million of unsecured Market-Linked Notes due January 7 2027 that are fully and unconditionally guaranteed by Morgan Stanley. The notes are linked to the performance of the S&P 500 Index (initial level 6,279.35) and are designed for investors seeking principal protection with limited equity-linked upside.

Key economic terms

  • Denomination / Issue price: $1,000 per note
  • Aggregate principal: $5,070,000
  • Maturity: 18 months (Issue 9 Jul 2025 – Maturity 7 Jan 2027)
  • Payment at maturity: • If Final Level > Initial Level: Principal + 100% of Underlier % Change, capped at $1,081.50 (108.15% of principal) • If Final Level ≤ Initial Level: return of principal only
  • Participation rate: 100%
  • Maximum return: 8.15% over 18 months
  • Interest: None; zero-coupon structure
  • Estimated value on pricing date: $985.00 (1.5% below issue price) driven by issuer funding rate and structuring costs
  • Distribution: Sold through Morgan Stanley & Co. to fee-based advisory accounts; no sales commission, but MS affiliates earn structuring/hedging income
  • Listing: Not listed; secondary liquidity only through MS&Co., if any
  • CUSIP / ISIN: 61778NER8 / US61778NER89

Investor considerations

  • Principal protection: The notes repay at least the $1,000 face amount at maturity, subject to Morgan Stanley credit risk.
  • Limited upside: Returns are capped at 8.15%, so any S&P 500 gain above ~8.15% over the term does not increase investor payout.
  • No current income: Investors forgo coupons and may face negative real returns if the index is flat or down.
  • Credit & liquidity risk: Unsecured obligations of MSFL/Morgan Stanley; notes are unlisted and secondary trading may be limited and at a discount.
  • Tax treatment: Expected to be treated as contingent payment debt instruments (CPDIs); U.S. holders must accrue OID income annually; projected comparable yield 4.118%.

Risk highlights (excerpted)

  • Market value driven by underlier performance, volatility, interest rates and Morgan Stanley credit spreads.
  • Estimated value is model-based and may differ from secondary prices.
  • Adjustment, calculation-agent discretion and potential conflicts of interest reside with MS & Co.
  • Non-U.S. holders: issuer expects Section 871(m) not to apply (delta<1); no gross-up for any withholding tax.

Use of proceeds & conflicts

  • Proceeds used for general corporate purposes and hedging.
  • FINRA Rule 5121 applies; Morgan Stanley affiliates face inherent conflicts as issuer, guarantor, calculation agent and market-maker.

Overall, the product offers short-dated principal protection with modest equity-linked upside, appropriate for fee-based clients prioritising capital preservation over high return potential. From a corporate perspective, the $5.07 million issuance is immaterial to Morgan Stanley’s balance sheet and earnings.

Morgan Stanley Finance LLC (Programma Serie A Global MTN) ha depositato il Supplemento di Prezzo n. 9.145 per 5,07 milioni di dollari di Note non garantite collegate al mercato con scadenza 7 gennaio 2027, garantite in modo pieno e incondizionato da Morgan Stanley. Le note sono collegate alla performance dell'Indice S&P 500 (livello iniziale 6.279,35) e sono pensate per investitori che cercano protezione del capitale con un limitato potenziale di rendimento azionario.

Termini economici chiave

  • Valore nominale / Prezzo di emissione: 1.000 dollari per nota
  • Capitale aggregato: 5.070.000 dollari
  • Scadenza: 18 mesi (Emissione 9 lug 2025 – Scadenza 7 gen 2027)
  • Pagamento a scadenza: • Se il Livello Finale > Livello Iniziale: Capitale + 100% della variazione percentuale dell’attivo sottostante, con un tetto a 1.081,50 $ (108,15% del capitale) • Se il Livello Finale ≤ Livello Iniziale: restituzione del solo capitale
  • Percentuale di partecipazione: 100%
  • Rendimento massimo: 8,15% su 18 mesi
  • Interessi: Nessuno; struttura zero-coupon
  • Valore stimato alla data di prezzo: 985,00 $ (1,5% sotto il prezzo di emissione) dovuto al tasso di finanziamento dell’emittente e ai costi di strutturazione
  • Distribuzione: Venduto tramite Morgan Stanley & Co. a conti di consulenza a parcella; nessuna commissione di vendita, ma le affiliate MS guadagnano dal structuring e hedging
  • Quotazione: Non quotato; liquidità secondaria solo tramite MS&Co., se disponibile
  • CUSIP / ISIN: 61778NER8 / US61778NER89

Considerazioni per gli investitori

  • Protezione del capitale: Le note rimborsano almeno il valore nominale di 1.000 $ a scadenza, soggetto al rischio di credito di Morgan Stanley.
  • Potenziale limitato: I rendimenti sono limitati all’8,15%, quindi qualsiasi guadagno dell’S&P 500 superiore a ~8,15% nel periodo non aumenta il pagamento all’investitore.
  • Nessun reddito corrente: Gli investitori rinunciano a cedole e potrebbero subire rendimenti reali negativi se l’indice resta stabile o scende.
  • Rischio di credito e liquidità: Obbligazioni non garantite di MSFL/Morgan Stanley; le note non sono quotate e la negoziazione secondaria può essere limitata e a sconto.
  • Trattamento fiscale: Previsto come strumenti di debito con pagamento condizionato (CPDI); i possessori statunitensi devono imputare reddito OID annualmente; rendimento comparabile stimato 4,118%.

Rischi principali (estratto)

  • Il valore di mercato dipende dalla performance dell’attivo sottostante, volatilità, tassi di interesse e spread di credito Morgan Stanley.
  • Il valore stimato è basato su modelli e può differire dai prezzi secondari.
  • La discrezionalità per aggiustamenti, calcolo e potenziali conflitti di interesse è di MS & Co.
  • Per i possessori non statunitensi: l’emittente prevede che la Sezione 871(m) non si applichi (delta <1); nessun aumento per ritenute fiscali.

Utilizzo dei proventi e conflitti

  • I proventi saranno utilizzati per scopi societari generali e coperture.
  • Si applica la Regola FINRA 5121; le affiliate di Morgan Stanley affrontano conflitti intrinseci come emittente, garante, agente di calcolo e market maker.

In sintesi, il prodotto offre protezione del capitale a breve termine con un modesto potenziale di rendimento azionario, adatto a clienti a parcella che privilegiano la conservazione del capitale rispetto a rendimenti elevati. Dal punto di vista aziendale, l’emissione da 5,07 milioni di dollari è irrilevante per il bilancio e gli utili di Morgan Stanley.

Morgan Stanley Finance LLC (Programa Global MTN Serie A) ha presentado el Suplemento de Precio No. 9,145 por 5,07 millones de dólares en Notas sin garantía vinculadas al mercado con vencimiento el 7 de enero de 2027, garantizadas total e incondicionalmente por Morgan Stanley. Las notas están ligadas al desempeño del Índice S&P 500 (nivel inicial 6,279.35) y están diseñadas para inversores que buscan protección del capital con un potencial limitado de ganancias vinculadas a acciones.

Términos económicos clave

  • Denominación / Precio de emisión: 1,000 dólares por nota
  • Principal agregado: 5,070,000 dólares
  • Vencimiento: 18 meses (Emisión 9 jul 2025 – Vencimiento 7 ene 2027)
  • Pago al vencimiento: • Si el Nivel Final > Nivel Inicial: Principal + 100% del cambio porcentual del subyacente, con un tope de $1,081.50 (108.15% del principal) • Si el Nivel Final ≤ Nivel Inicial: devolución del solo principal
  • Tasa de participación: 100%
  • Retorno máximo: 8.15% en 18 meses
  • Intereses: Ninguno; estructura cupón cero
  • Valor estimado en la fecha de precio: $985.00 (1.5% por debajo del precio de emisión) debido a la tasa de financiación del emisor y costos de estructuración
  • Distribución: Vendido a través de Morgan Stanley & Co. a cuentas de asesoría con tarifa; sin comisión de venta, pero afiliados de MS obtienen ingresos por estructuración/cobertura
  • Listado: No listado; liquidez secundaria solo a través de MS&Co., si existe
  • CUSIP / ISIN: 61778NER8 / US61778NER89

Consideraciones para inversores

  • Protección del capital: Las notas reembolsan al menos el valor nominal de $1,000 al vencimiento, sujeto al riesgo crediticio de Morgan Stanley.
  • Potencial limitado: Los retornos están limitados al 8.15%, por lo que cualquier ganancia del S&P 500 superior a ~8.15% durante el plazo no aumenta el pago al inversor.
  • Sin ingreso actual: Los inversores renuncian a cupones y podrían enfrentar rendimientos reales negativos si el índice se mantiene plano o baja.
  • Riesgo de crédito y liquidez: Obligaciones no garantizadas de MSFL/Morgan Stanley; las notas no están listadas y el comercio secundario puede ser limitado y con descuento.
  • Tratamiento fiscal: Se espera que se traten como instrumentos de deuda con pago contingente (CPDI); los titulares estadounidenses deben acumular ingresos OID anualmente; rendimiento comparable proyectado 4.118%.

Aspectos destacados de riesgo (extracto)

  • El valor de mercado está influenciado por el desempeño del subyacente, volatilidad, tasas de interés y spreads crediticios de Morgan Stanley.
  • El valor estimado es basado en modelos y puede diferir de los precios secundarios.
  • La discreción para ajustes, cálculo y posibles conflictos de interés reside en MS & Co.
  • Tenedores no estadounidenses: el emisor espera que la Sección 871(m) no se aplique (delta <1); sin incremento por retenciones fiscales.

Uso de los ingresos y conflictos

  • Los ingresos se usarán para fines corporativos generales y coberturas.
  • Se aplica la Regla FINRA 5121; las afiliadas de Morgan Stanley enfrentan conflictos inherentes como emisor, garante, agente de cálculo y creador de mercado.

En resumen, el producto ofrece protección del capital a corto plazo con un modesto potencial de ganancias vinculadas a acciones, adecuado para clientes con asesoría basada en tarifas que priorizan la preservación del capital sobre altos rendimientos. Desde una perspectiva corporativa, la emisión de 5,07 millones de dólares es insignificante para el balance y ganancias de Morgan Stanley.

Morgan Stanley Finance LLC(시리즈 A 글로벌 MTN 프로그램)는 2027년 1월 7일 만기되는 507만 달러 규모의 무담보 시장 연계 채권에 대해 가격 보충서 9,145호를 제출했으며, 이는 Morgan Stanley가 전액 무조건 보증합니다. 이 채권은 S&P 500 지수(초기 수준 6,279.35)의 성과에 연동되며, 원금 보호와 제한된 주식 연계 상승을 원하는 투자자를 위해 설계되었습니다.

주요 경제 조건

  • 액면가 / 발행가: 채권당 1,000달러
  • 총 원금: 5,070,000달러
  • 만기: 18개월 (2025년 7월 9일 발행 – 2027년 1월 7일 만기)
  • 만기 지급: • 최종 수준이 초기 수준 초과 시: 원금 + 기초자산 변동률 100%, 최대 1,081.50달러 (원금의 108.15%) • 최종 수준이 초기 수준 이하 시: 원금만 반환
  • 참여율: 100%
  • 최대 수익률: 18개월 동안 8.15%
  • 이자: 없음; 제로 쿠폰 구조
  • 가격 책정일 추정 가치: 985.00달러 (발행가 대비 1.5% 낮음), 발행자 자금 조달 비용 및 구조화 비용 반영
  • 배포: Morgan Stanley & Co.를 통해 수수료 기반 자문 계좌에 판매; 판매 수수료 없음, 그러나 MS 계열사는 구조화/헤지 수익 획득
  • 상장: 비상장; 2차 유동성은 MS&Co.를 통해서만 가능할 수 있음
  • CUSIP / ISIN: 61778NER8 / US61778NER89

투자자 고려사항

  • 원금 보호: 만기 시 최소 1,000달러 원금 상환, 단 Morgan Stanley 신용위험에 노출됨.
  • 제한된 상승 잠재력: 수익률은 8.15%로 제한되며, 기간 동안 S&P 500 지수가 약 8.15%를 초과 상승해도 투자자 지급액은 증가하지 않음.
  • 현재 수익 없음: 투자자는 쿠폰을 포기하며, 지수가 횡보하거나 하락하면 실질 수익률이 마이너스일 수 있음.
  • 신용 및 유동성 위험: MSFL/Morgan Stanley의 무담보 채무; 비상장 채권이며 2차 거래가 제한적이고 할인 거래될 수 있음.
  • 세금 처리: 조건부 지급 채무증권(CPDI)으로 분류 예상; 미국 보유자는 매년 OID 소득을 인식해야 하며, 예상 유사 수익률은 4.118%임.

위험 요약 (발췌)

  • 시장 가치는 기초자산 성과, 변동성, 금리 및 Morgan Stanley 신용 스프레드에 의해 좌우됨.
  • 추정 가치는 모델 기반이며 2차 가격과 다를 수 있음.
  • 조정, 계산 대리인 재량 및 잠재적 이해상충은 MS & Co.에 있음.
  • 비미국 보유자: 발행자는 섹션 871(m)이 적용되지 않을 것으로 예상(델타<1); 원천징수세에 대한 추가 부담 없음.

수익금 용도 및 이해상충

  • 수익금은 일반 기업 목적 및 헤지에 사용됨.
  • FINRA 규칙 5121 적용; Morgan Stanley 계열사는 발행자, 보증인, 계산 대리인 및 마켓 메이커로서 본질적 이해상충 존재.

전반적으로 이 상품은 단기 원금 보호와 제한적 주식 연계 상승을 제공하며, 수수료 기반 고객 중 자본 보전을 우선시하는 투자자에게 적합합니다. 기업 관점에서 507만 달러 규모 발행은 Morgan Stanley의 재무상태 및 수익에 미미한 영향만 미칩니다.

Morgan Stanley Finance LLC (Programme MTN Global Série A) a déposé le Supplément de Prix n° 9 145 pour 5,07 millions de dollars de Notes non sécurisées liées au marché arrivant à échéance le 7 janvier 2027, garanties de manière intégrale et inconditionnelle par Morgan Stanley. Les notes sont liées à la performance de l'Indice S&P 500 (niveau initial 6 279,35) et sont conçues pour les investisseurs recherchant une protection du capital avec un potentiel limité de hausse liée aux actions.

Principaux termes économiques

  • Valeur nominale / Prix d’émission : 1 000 $ par note
  • Principal agrégé : 5 070 000 $
  • Échéance : 18 mois (Émission 9 juil. 2025 – Échéance 7 janv. 2027)
  • Remboursement à l’échéance : • Si le niveau final > niveau initial : principal + 100 % de la variation en pourcentage de l’actif sous-jacent, plafonné à 1 081,50 $ (108,15 % du principal) • Si le niveau final ≤ niveau initial : remboursement du seul principal
  • Taux de participation : 100 %
  • Rendement maximal : 8,15 % sur 18 mois
  • Intérêts : Aucun ; structure zéro-coupon
  • Valeur estimée à la date de tarification : 985,00 $ (1,5 % en dessous du prix d’émission) en raison du taux de financement de l’émetteur et des coûts de structuration
  • Distribution : Vendu via Morgan Stanley & Co. à des comptes de conseil rémunérés ; pas de commission de vente, mais les filiales de MS perçoivent des revenus de structuration/couverture
  • Cotation : Non coté ; liquidité secondaire uniquement via MS&Co., si disponible
  • CUSIP / ISIN : 61778NER8 / US61778NER89

Considérations pour les investisseurs

  • Protection du capital : Les notes remboursent au moins la valeur nominale de 1 000 $ à l’échéance, sous réserve du risque de crédit de Morgan Stanley.
  • Potentiel limité : Les rendements sont plafonnés à 8,15 %, donc toute hausse de l’S&P 500 supérieure à environ 8,15 % sur la durée ne majorera pas le paiement à l’investisseur.
  • Pas de revenu courant : Les investisseurs renoncent aux coupons et peuvent subir des rendements réels négatifs si l’indice reste stable ou baisse.
  • Risque de crédit et de liquidité : Obligations non sécurisées de MSFL/Morgan Stanley ; les notes ne sont pas cotées et la négociation secondaire peut être limitée et à prix réduit.
  • Traitement fiscal : Devrait être traité comme des instruments de dette à paiement conditionnel (CPDI) ; les détenteurs américains doivent comptabiliser un revenu OID annuel ; rendement comparable projeté de 4,118 %.

Points clés sur les risques (extrait)

  • La valeur de marché est influencée par la performance de l’actif sous-jacent, la volatilité, les taux d’intérêt et les écarts de crédit Morgan Stanley.
  • La valeur estimée est basée sur un modèle et peut différer des prix secondaires.
  • Les ajustements, la discrétion de l’agent de calcul et les conflits d’intérêts potentiels sont sous la responsabilité de MS & Co.
  • Détenteurs non américains : l’émetteur s’attend à ce que la Section 871(m) ne s’applique pas (delta <1) ; pas de majoration pour retenue à la source.

Utilisation des fonds et conflits

  • Les fonds seront utilisés à des fins générales d’entreprise et de couverture.
  • La règle FINRA 5121 s’applique ; les filiales de Morgan Stanley font face à des conflits d’intérêts inhérents en tant qu’émetteur, garant, agent de calcul et teneur de marché.

Dans l’ensemble, le produit offre une protection du capital à court terme avec un potentiel modeste de hausse liée aux actions, adapté aux clients facturés sur la base de frais qui privilégient la préservation du capital plutôt que des rendements élevés. D’un point de vue corporatif, l’émission de 5,07 millions de dollars est négligeable pour le bilan et les résultats de Morgan Stanley.

Morgan Stanley Finance LLC (Serie A Global MTN Programm) hat den Preiszusatz Nr. 9.145 für unbesicherte marktgebundene Schuldverschreibungen in Höhe von 5,07 Millionen US-Dollar mit Fälligkeit am 7. Januar 2027 eingereicht, die von Morgan Stanley vollständig und bedingungslos garantiert werden. Die Schuldverschreibungen sind an die Entwicklung des S&P 500 Index (Anfangswert 6.279,35) gekoppelt und richten sich an Anleger, die Kapitalschutz mit begrenztem aktienbezogenen Aufwärtspotenzial suchen.

Wesentliche wirtschaftliche Bedingungen

  • Nennwert / Ausgabepreis: 1.000 USD pro Note
  • Gesamtnennbetrag: 5.070.000 USD
  • Laufzeit: 18 Monate (Emission 9. Juli 2025 – Fälligkeit 7. Januar 2027)
  • Zahlung bei Fälligkeit: • Wenn Endstand > Anfangsstand: Kapital + 100 % der prozentualen Veränderung des Basiswerts, begrenzt auf 1.081,50 USD (108,15 % des Kapitals) • Wenn Endstand ≤ Anfangsstand: Rückzahlung des Kapitals allein
  • Partizipationsrate: 100 %
  • Maximale Rendite: 8,15 % über 18 Monate
  • Zinsen: Keine; Nullkuponstruktur
  • Geschätzter Wert am Preisfeststellungstag: 985,00 USD (1,5 % unter dem Ausgabepreis), bedingt durch Emittentenfinanzierungsrate und Strukturierungskosten
  • Vertrieb: Verkauf über Morgan Stanley & Co. an gebührenbasierte Beratungskonten; keine Verkaufsprovision, aber MS-Tochtergesellschaften erzielen Erträge aus Strukturierung und Absicherung
  • Notierung: Nicht börsennotiert; Sekundärliquidität nur über MS&Co., falls vorhanden
  • CUSIP / ISIN: 61778NER8 / US61778NER89

Überlegungen für Anleger

  • Kapitalschutz: Die Notes zahlen mindestens den Nennwert von 1.000 USD bei Fälligkeit zurück, vorbehaltlich des Kreditrisikos von Morgan Stanley.
  • Begrenztes Aufwärtspotenzial: Die Renditen sind auf 8,15 % begrenzt, sodass jeglicher S&P 500-Anstieg über ca. 8,15 % während der Laufzeit die Auszahlung an den Anleger nicht erhöht.
  • Keine laufenden Erträge: Anleger verzichten auf Kupons und können negative reale Renditen erleiden, wenn der Index seitwärts tendiert oder fällt.
  • Kredit- und Liquiditätsrisiko: Ungesicherte Verbindlichkeiten von MSFL/Morgan Stanley; die Notes sind nicht börsennotiert und der Sekundärhandel kann eingeschränkt und mit Abschlag erfolgen.
  • Steuerliche Behandlung: Voraussichtlich als bedingte Schuldverschreibungen (CPDI) behandelt; US-Inhaber müssen jährlich OID-Einkünfte erfassen; projizierte vergleichbare Rendite 4,118 %.

Risikohighlights (Auszug)

  • Marktwert wird durch die Performance des Basiswerts, Volatilität, Zinssätze und Morgan Stanley-Kreditspreads bestimmt.
  • Der geschätzte Wert basiert auf Modellen und kann von Sekundärpreisen abweichen.
  • Anpassungen, Berechnungsagenten-Ermessen und potenzielle Interessenkonflikte liegen bei MS & Co.
  • Nicht-US-Inhaber: Emittent erwartet, dass Abschnitt 871(m) nicht anwendbar ist (Delta<1); keine Bruttoaufstockung für Quellensteuer.

Verwendung der Erlöse & Interessenkonflikte

  • Erlöse werden für allgemeine Unternehmenszwecke und Absicherungen verwendet.
  • FINRA-Regel 5121 gilt; Morgan Stanley-Tochtergesellschaften stehen als Emittent, Garantiegeber, Berechnungsagent und Market Maker in inhärenten Interessenkonflikten.

Insgesamt bietet das Produkt kurzfristigen Kapitalschutz mit bescheidenem aktienbezogenem Aufwärtspotenzial und eignet sich für gebührenbasierte Kunden, die Kapitalerhalt gegenüber hohen Erträgen priorisieren. Aus Unternehmenssicht ist die Emission von 5,07 Millionen US-Dollar für die Bilanz und das Ergebnis von Morgan Stanley unerheblich.

Positive
  • Principal protection: investors receive no less than the $1,000 face amount at maturity, protecting capital barring issuer default.
  • 100% upside participation in S&P 500 appreciation, allowing equity exposure within the cap.
  • Morgan Stanley guarantee adds high-grade credit backing.
  • Low distribution costs (0.65% of face) relative to typical retail structured notes.
Negative
  • Upside capped at 8.15%, limiting potential return if the S&P 500 gains strongly.
  • No coupons; investors forego current income and may underperform inflation if index is flat/down.
  • Estimated value ($985) below issue price implies 1.5% initial value erosion.
  • Liquidity risk: unlisted notes rely on MS&Co. for secondary market; sales may occur at significant discounts.
  • Credit risk of Morgan Stanley; principal protection lost if issuer/guarantor defaults.
  • Unfavorable tax treatment as CPDI requires annual OID accruals.

Insights

TL;DR Small, principal-protected note offers 100% upside to S&P 500 but caps gains at 8.15%; immaterial to MS, neutral for shareholders.

Materiality & impact: The $5.07 million issuance is negligible relative to Morgan Stanley’s funding base; therefore, it is not impactful for MS equity holders. For investors evaluating the note itself, the structure provides full principal return plus limited participation—essentially a short-term CD alternative with equity kicker.

Positives: • Full principal repayment at maturity • 100% participation up to cap • Morgan Stanley guarantee • Low distribution fee (0.65%).

Negatives: • Return ceiling of 8.15% could be quickly reached in a rising market • No periodic income • Estimated value $15 below issue price highlights embedded costs • Liquidity entirely dependent on MS&Co. • CPDI tax treatment accelerates income recognition.

Given limited upside and short tenor, the product suits conservative clients with equity outlook ≤8 % over 18 months. It provides diversification for fee-based platforms but does not alter Morgan Stanley’s financial profile.

Morgan Stanley Finance LLC (Programma Serie A Global MTN) ha depositato il Supplemento di Prezzo n. 9.145 per 5,07 milioni di dollari di Note non garantite collegate al mercato con scadenza 7 gennaio 2027, garantite in modo pieno e incondizionato da Morgan Stanley. Le note sono collegate alla performance dell'Indice S&P 500 (livello iniziale 6.279,35) e sono pensate per investitori che cercano protezione del capitale con un limitato potenziale di rendimento azionario.

Termini economici chiave

  • Valore nominale / Prezzo di emissione: 1.000 dollari per nota
  • Capitale aggregato: 5.070.000 dollari
  • Scadenza: 18 mesi (Emissione 9 lug 2025 – Scadenza 7 gen 2027)
  • Pagamento a scadenza: • Se il Livello Finale > Livello Iniziale: Capitale + 100% della variazione percentuale dell’attivo sottostante, con un tetto a 1.081,50 $ (108,15% del capitale) • Se il Livello Finale ≤ Livello Iniziale: restituzione del solo capitale
  • Percentuale di partecipazione: 100%
  • Rendimento massimo: 8,15% su 18 mesi
  • Interessi: Nessuno; struttura zero-coupon
  • Valore stimato alla data di prezzo: 985,00 $ (1,5% sotto il prezzo di emissione) dovuto al tasso di finanziamento dell’emittente e ai costi di strutturazione
  • Distribuzione: Venduto tramite Morgan Stanley & Co. a conti di consulenza a parcella; nessuna commissione di vendita, ma le affiliate MS guadagnano dal structuring e hedging
  • Quotazione: Non quotato; liquidità secondaria solo tramite MS&Co., se disponibile
  • CUSIP / ISIN: 61778NER8 / US61778NER89

Considerazioni per gli investitori

  • Protezione del capitale: Le note rimborsano almeno il valore nominale di 1.000 $ a scadenza, soggetto al rischio di credito di Morgan Stanley.
  • Potenziale limitato: I rendimenti sono limitati all’8,15%, quindi qualsiasi guadagno dell’S&P 500 superiore a ~8,15% nel periodo non aumenta il pagamento all’investitore.
  • Nessun reddito corrente: Gli investitori rinunciano a cedole e potrebbero subire rendimenti reali negativi se l’indice resta stabile o scende.
  • Rischio di credito e liquidità: Obbligazioni non garantite di MSFL/Morgan Stanley; le note non sono quotate e la negoziazione secondaria può essere limitata e a sconto.
  • Trattamento fiscale: Previsto come strumenti di debito con pagamento condizionato (CPDI); i possessori statunitensi devono imputare reddito OID annualmente; rendimento comparabile stimato 4,118%.

Rischi principali (estratto)

  • Il valore di mercato dipende dalla performance dell’attivo sottostante, volatilità, tassi di interesse e spread di credito Morgan Stanley.
  • Il valore stimato è basato su modelli e può differire dai prezzi secondari.
  • La discrezionalità per aggiustamenti, calcolo e potenziali conflitti di interesse è di MS & Co.
  • Per i possessori non statunitensi: l’emittente prevede che la Sezione 871(m) non si applichi (delta <1); nessun aumento per ritenute fiscali.

Utilizzo dei proventi e conflitti

  • I proventi saranno utilizzati per scopi societari generali e coperture.
  • Si applica la Regola FINRA 5121; le affiliate di Morgan Stanley affrontano conflitti intrinseci come emittente, garante, agente di calcolo e market maker.

In sintesi, il prodotto offre protezione del capitale a breve termine con un modesto potenziale di rendimento azionario, adatto a clienti a parcella che privilegiano la conservazione del capitale rispetto a rendimenti elevati. Dal punto di vista aziendale, l’emissione da 5,07 milioni di dollari è irrilevante per il bilancio e gli utili di Morgan Stanley.

Morgan Stanley Finance LLC (Programa Global MTN Serie A) ha presentado el Suplemento de Precio No. 9,145 por 5,07 millones de dólares en Notas sin garantía vinculadas al mercado con vencimiento el 7 de enero de 2027, garantizadas total e incondicionalmente por Morgan Stanley. Las notas están ligadas al desempeño del Índice S&P 500 (nivel inicial 6,279.35) y están diseñadas para inversores que buscan protección del capital con un potencial limitado de ganancias vinculadas a acciones.

Términos económicos clave

  • Denominación / Precio de emisión: 1,000 dólares por nota
  • Principal agregado: 5,070,000 dólares
  • Vencimiento: 18 meses (Emisión 9 jul 2025 – Vencimiento 7 ene 2027)
  • Pago al vencimiento: • Si el Nivel Final > Nivel Inicial: Principal + 100% del cambio porcentual del subyacente, con un tope de $1,081.50 (108.15% del principal) • Si el Nivel Final ≤ Nivel Inicial: devolución del solo principal
  • Tasa de participación: 100%
  • Retorno máximo: 8.15% en 18 meses
  • Intereses: Ninguno; estructura cupón cero
  • Valor estimado en la fecha de precio: $985.00 (1.5% por debajo del precio de emisión) debido a la tasa de financiación del emisor y costos de estructuración
  • Distribución: Vendido a través de Morgan Stanley & Co. a cuentas de asesoría con tarifa; sin comisión de venta, pero afiliados de MS obtienen ingresos por estructuración/cobertura
  • Listado: No listado; liquidez secundaria solo a través de MS&Co., si existe
  • CUSIP / ISIN: 61778NER8 / US61778NER89

Consideraciones para inversores

  • Protección del capital: Las notas reembolsan al menos el valor nominal de $1,000 al vencimiento, sujeto al riesgo crediticio de Morgan Stanley.
  • Potencial limitado: Los retornos están limitados al 8.15%, por lo que cualquier ganancia del S&P 500 superior a ~8.15% durante el plazo no aumenta el pago al inversor.
  • Sin ingreso actual: Los inversores renuncian a cupones y podrían enfrentar rendimientos reales negativos si el índice se mantiene plano o baja.
  • Riesgo de crédito y liquidez: Obligaciones no garantizadas de MSFL/Morgan Stanley; las notas no están listadas y el comercio secundario puede ser limitado y con descuento.
  • Tratamiento fiscal: Se espera que se traten como instrumentos de deuda con pago contingente (CPDI); los titulares estadounidenses deben acumular ingresos OID anualmente; rendimiento comparable proyectado 4.118%.

Aspectos destacados de riesgo (extracto)

  • El valor de mercado está influenciado por el desempeño del subyacente, volatilidad, tasas de interés y spreads crediticios de Morgan Stanley.
  • El valor estimado es basado en modelos y puede diferir de los precios secundarios.
  • La discreción para ajustes, cálculo y posibles conflictos de interés reside en MS & Co.
  • Tenedores no estadounidenses: el emisor espera que la Sección 871(m) no se aplique (delta <1); sin incremento por retenciones fiscales.

Uso de los ingresos y conflictos

  • Los ingresos se usarán para fines corporativos generales y coberturas.
  • Se aplica la Regla FINRA 5121; las afiliadas de Morgan Stanley enfrentan conflictos inherentes como emisor, garante, agente de cálculo y creador de mercado.

En resumen, el producto ofrece protección del capital a corto plazo con un modesto potencial de ganancias vinculadas a acciones, adecuado para clientes con asesoría basada en tarifas que priorizan la preservación del capital sobre altos rendimientos. Desde una perspectiva corporativa, la emisión de 5,07 millones de dólares es insignificante para el balance y ganancias de Morgan Stanley.

Morgan Stanley Finance LLC(시리즈 A 글로벌 MTN 프로그램)는 2027년 1월 7일 만기되는 507만 달러 규모의 무담보 시장 연계 채권에 대해 가격 보충서 9,145호를 제출했으며, 이는 Morgan Stanley가 전액 무조건 보증합니다. 이 채권은 S&P 500 지수(초기 수준 6,279.35)의 성과에 연동되며, 원금 보호와 제한된 주식 연계 상승을 원하는 투자자를 위해 설계되었습니다.

주요 경제 조건

  • 액면가 / 발행가: 채권당 1,000달러
  • 총 원금: 5,070,000달러
  • 만기: 18개월 (2025년 7월 9일 발행 – 2027년 1월 7일 만기)
  • 만기 지급: • 최종 수준이 초기 수준 초과 시: 원금 + 기초자산 변동률 100%, 최대 1,081.50달러 (원금의 108.15%) • 최종 수준이 초기 수준 이하 시: 원금만 반환
  • 참여율: 100%
  • 최대 수익률: 18개월 동안 8.15%
  • 이자: 없음; 제로 쿠폰 구조
  • 가격 책정일 추정 가치: 985.00달러 (발행가 대비 1.5% 낮음), 발행자 자금 조달 비용 및 구조화 비용 반영
  • 배포: Morgan Stanley & Co.를 통해 수수료 기반 자문 계좌에 판매; 판매 수수료 없음, 그러나 MS 계열사는 구조화/헤지 수익 획득
  • 상장: 비상장; 2차 유동성은 MS&Co.를 통해서만 가능할 수 있음
  • CUSIP / ISIN: 61778NER8 / US61778NER89

투자자 고려사항

  • 원금 보호: 만기 시 최소 1,000달러 원금 상환, 단 Morgan Stanley 신용위험에 노출됨.
  • 제한된 상승 잠재력: 수익률은 8.15%로 제한되며, 기간 동안 S&P 500 지수가 약 8.15%를 초과 상승해도 투자자 지급액은 증가하지 않음.
  • 현재 수익 없음: 투자자는 쿠폰을 포기하며, 지수가 횡보하거나 하락하면 실질 수익률이 마이너스일 수 있음.
  • 신용 및 유동성 위험: MSFL/Morgan Stanley의 무담보 채무; 비상장 채권이며 2차 거래가 제한적이고 할인 거래될 수 있음.
  • 세금 처리: 조건부 지급 채무증권(CPDI)으로 분류 예상; 미국 보유자는 매년 OID 소득을 인식해야 하며, 예상 유사 수익률은 4.118%임.

위험 요약 (발췌)

  • 시장 가치는 기초자산 성과, 변동성, 금리 및 Morgan Stanley 신용 스프레드에 의해 좌우됨.
  • 추정 가치는 모델 기반이며 2차 가격과 다를 수 있음.
  • 조정, 계산 대리인 재량 및 잠재적 이해상충은 MS & Co.에 있음.
  • 비미국 보유자: 발행자는 섹션 871(m)이 적용되지 않을 것으로 예상(델타<1); 원천징수세에 대한 추가 부담 없음.

수익금 용도 및 이해상충

  • 수익금은 일반 기업 목적 및 헤지에 사용됨.
  • FINRA 규칙 5121 적용; Morgan Stanley 계열사는 발행자, 보증인, 계산 대리인 및 마켓 메이커로서 본질적 이해상충 존재.

전반적으로 이 상품은 단기 원금 보호와 제한적 주식 연계 상승을 제공하며, 수수료 기반 고객 중 자본 보전을 우선시하는 투자자에게 적합합니다. 기업 관점에서 507만 달러 규모 발행은 Morgan Stanley의 재무상태 및 수익에 미미한 영향만 미칩니다.

Morgan Stanley Finance LLC (Programme MTN Global Série A) a déposé le Supplément de Prix n° 9 145 pour 5,07 millions de dollars de Notes non sécurisées liées au marché arrivant à échéance le 7 janvier 2027, garanties de manière intégrale et inconditionnelle par Morgan Stanley. Les notes sont liées à la performance de l'Indice S&P 500 (niveau initial 6 279,35) et sont conçues pour les investisseurs recherchant une protection du capital avec un potentiel limité de hausse liée aux actions.

Principaux termes économiques

  • Valeur nominale / Prix d’émission : 1 000 $ par note
  • Principal agrégé : 5 070 000 $
  • Échéance : 18 mois (Émission 9 juil. 2025 – Échéance 7 janv. 2027)
  • Remboursement à l’échéance : • Si le niveau final > niveau initial : principal + 100 % de la variation en pourcentage de l’actif sous-jacent, plafonné à 1 081,50 $ (108,15 % du principal) • Si le niveau final ≤ niveau initial : remboursement du seul principal
  • Taux de participation : 100 %
  • Rendement maximal : 8,15 % sur 18 mois
  • Intérêts : Aucun ; structure zéro-coupon
  • Valeur estimée à la date de tarification : 985,00 $ (1,5 % en dessous du prix d’émission) en raison du taux de financement de l’émetteur et des coûts de structuration
  • Distribution : Vendu via Morgan Stanley & Co. à des comptes de conseil rémunérés ; pas de commission de vente, mais les filiales de MS perçoivent des revenus de structuration/couverture
  • Cotation : Non coté ; liquidité secondaire uniquement via MS&Co., si disponible
  • CUSIP / ISIN : 61778NER8 / US61778NER89

Considérations pour les investisseurs

  • Protection du capital : Les notes remboursent au moins la valeur nominale de 1 000 $ à l’échéance, sous réserve du risque de crédit de Morgan Stanley.
  • Potentiel limité : Les rendements sont plafonnés à 8,15 %, donc toute hausse de l’S&P 500 supérieure à environ 8,15 % sur la durée ne majorera pas le paiement à l’investisseur.
  • Pas de revenu courant : Les investisseurs renoncent aux coupons et peuvent subir des rendements réels négatifs si l’indice reste stable ou baisse.
  • Risque de crédit et de liquidité : Obligations non sécurisées de MSFL/Morgan Stanley ; les notes ne sont pas cotées et la négociation secondaire peut être limitée et à prix réduit.
  • Traitement fiscal : Devrait être traité comme des instruments de dette à paiement conditionnel (CPDI) ; les détenteurs américains doivent comptabiliser un revenu OID annuel ; rendement comparable projeté de 4,118 %.

Points clés sur les risques (extrait)

  • La valeur de marché est influencée par la performance de l’actif sous-jacent, la volatilité, les taux d’intérêt et les écarts de crédit Morgan Stanley.
  • La valeur estimée est basée sur un modèle et peut différer des prix secondaires.
  • Les ajustements, la discrétion de l’agent de calcul et les conflits d’intérêts potentiels sont sous la responsabilité de MS & Co.
  • Détenteurs non américains : l’émetteur s’attend à ce que la Section 871(m) ne s’applique pas (delta <1) ; pas de majoration pour retenue à la source.

Utilisation des fonds et conflits

  • Les fonds seront utilisés à des fins générales d’entreprise et de couverture.
  • La règle FINRA 5121 s’applique ; les filiales de Morgan Stanley font face à des conflits d’intérêts inhérents en tant qu’émetteur, garant, agent de calcul et teneur de marché.

Dans l’ensemble, le produit offre une protection du capital à court terme avec un potentiel modeste de hausse liée aux actions, adapté aux clients facturés sur la base de frais qui privilégient la préservation du capital plutôt que des rendements élevés. D’un point de vue corporatif, l’émission de 5,07 millions de dollars est négligeable pour le bilan et les résultats de Morgan Stanley.

Morgan Stanley Finance LLC (Serie A Global MTN Programm) hat den Preiszusatz Nr. 9.145 für unbesicherte marktgebundene Schuldverschreibungen in Höhe von 5,07 Millionen US-Dollar mit Fälligkeit am 7. Januar 2027 eingereicht, die von Morgan Stanley vollständig und bedingungslos garantiert werden. Die Schuldverschreibungen sind an die Entwicklung des S&P 500 Index (Anfangswert 6.279,35) gekoppelt und richten sich an Anleger, die Kapitalschutz mit begrenztem aktienbezogenen Aufwärtspotenzial suchen.

Wesentliche wirtschaftliche Bedingungen

  • Nennwert / Ausgabepreis: 1.000 USD pro Note
  • Gesamtnennbetrag: 5.070.000 USD
  • Laufzeit: 18 Monate (Emission 9. Juli 2025 – Fälligkeit 7. Januar 2027)
  • Zahlung bei Fälligkeit: • Wenn Endstand > Anfangsstand: Kapital + 100 % der prozentualen Veränderung des Basiswerts, begrenzt auf 1.081,50 USD (108,15 % des Kapitals) • Wenn Endstand ≤ Anfangsstand: Rückzahlung des Kapitals allein
  • Partizipationsrate: 100 %
  • Maximale Rendite: 8,15 % über 18 Monate
  • Zinsen: Keine; Nullkuponstruktur
  • Geschätzter Wert am Preisfeststellungstag: 985,00 USD (1,5 % unter dem Ausgabepreis), bedingt durch Emittentenfinanzierungsrate und Strukturierungskosten
  • Vertrieb: Verkauf über Morgan Stanley & Co. an gebührenbasierte Beratungskonten; keine Verkaufsprovision, aber MS-Tochtergesellschaften erzielen Erträge aus Strukturierung und Absicherung
  • Notierung: Nicht börsennotiert; Sekundärliquidität nur über MS&Co., falls vorhanden
  • CUSIP / ISIN: 61778NER8 / US61778NER89

Überlegungen für Anleger

  • Kapitalschutz: Die Notes zahlen mindestens den Nennwert von 1.000 USD bei Fälligkeit zurück, vorbehaltlich des Kreditrisikos von Morgan Stanley.
  • Begrenztes Aufwärtspotenzial: Die Renditen sind auf 8,15 % begrenzt, sodass jeglicher S&P 500-Anstieg über ca. 8,15 % während der Laufzeit die Auszahlung an den Anleger nicht erhöht.
  • Keine laufenden Erträge: Anleger verzichten auf Kupons und können negative reale Renditen erleiden, wenn der Index seitwärts tendiert oder fällt.
  • Kredit- und Liquiditätsrisiko: Ungesicherte Verbindlichkeiten von MSFL/Morgan Stanley; die Notes sind nicht börsennotiert und der Sekundärhandel kann eingeschränkt und mit Abschlag erfolgen.
  • Steuerliche Behandlung: Voraussichtlich als bedingte Schuldverschreibungen (CPDI) behandelt; US-Inhaber müssen jährlich OID-Einkünfte erfassen; projizierte vergleichbare Rendite 4,118 %.

Risikohighlights (Auszug)

  • Marktwert wird durch die Performance des Basiswerts, Volatilität, Zinssätze und Morgan Stanley-Kreditspreads bestimmt.
  • Der geschätzte Wert basiert auf Modellen und kann von Sekundärpreisen abweichen.
  • Anpassungen, Berechnungsagenten-Ermessen und potenzielle Interessenkonflikte liegen bei MS & Co.
  • Nicht-US-Inhaber: Emittent erwartet, dass Abschnitt 871(m) nicht anwendbar ist (Delta<1); keine Bruttoaufstockung für Quellensteuer.

Verwendung der Erlöse & Interessenkonflikte

  • Erlöse werden für allgemeine Unternehmenszwecke und Absicherungen verwendet.
  • FINRA-Regel 5121 gilt; Morgan Stanley-Tochtergesellschaften stehen als Emittent, Garantiegeber, Berechnungsagent und Market Maker in inhärenten Interessenkonflikten.

Insgesamt bietet das Produkt kurzfristigen Kapitalschutz mit bescheidenem aktienbezogenem Aufwärtspotenzial und eignet sich für gebührenbasierte Kunden, die Kapitalerhalt gegenüber hohen Erträgen priorisieren. Aus Unternehmenssicht ist die Emission von 5,07 Millionen US-Dollar für die Bilanz und das Ergebnis von Morgan Stanley unerheblich.

Pricing Supplement No. 9,145

Registration Statement Nos. 333-275587; 333-275587-01

Dated July 3, 2025

Filed pursuant to Rule 424(b)(2)

Morgan Stanley Finance LLC

Structured Investments

Market-Linked Notes due January 7, 2027

Based on the Performance of the S&P 500® Index

Fully and Unconditionally Guaranteed by Morgan Stanley

The notes are unsecured obligations of Morgan Stanley Finance LLC (“MSFL”) and are fully and unconditionally guaranteed by Morgan Stanley. The notes will pay no interest and have the terms described in the accompanying product supplement, index supplement and prospectus, as supplemented or modified by this document.

Payment at maturity. At maturity, if the final level is greater than the initial level, investors will receive the stated principal amount plus the upside payment, subject to the maximum payment at maturity. If, however, the final level is equal to or less than the initial level, investors will receive only the stated principal amount at maturity.

The notes are for investors who are concerned about principal risk but seek a return based on the performance of the underlier, and who are willing to forgo current income and returns above the maximum payment at maturity in exchange for the repayment of principal at maturity and the potential to receive a positive return. The notes are notes issued as part of MSFL’s Series A Global Medium-Term Notes program.

All payments are subject to our credit risk. If we default on our obligations, you could lose some or all of your investment. These notes are not secured obligations and you will not have any security interest in, or otherwise have any access to, any underlying reference asset or assets.

FINAL TERMS

Issuer:

Morgan Stanley Finance LLC

Guarantor:

Morgan Stanley

Stated principal amount:

$1,000 per note&nbsp;

Issue price:

$1,000 per note (see “Commissions and issue price” below)&nbsp;

Aggregate principal amount:

$5,070,000

Underlier:

S&P 500® Index (the “underlying index”)

Strike date:

July 3, 2025

Pricing date:

July 3, 2025

Original issue date:

July 9, 2025

Observation date:

January 4, 2027, subject to postponement for non-trading days and certain market disruption events

Maturity date:

January 7, 2027

&nbsp;

Terms continued on the following page

Agent:

Morgan Stanley & Co. LLC (“MS & Co.”), an affiliate of MSFL and a wholly owned subsidiary of Morgan Stanley. See “Supplemental information regarding plan of distribution; conflicts of interest.”

Estimated value on the pricing date:

$985.00 per note. See “Estimated Value of the Notes” on page 3.

Commissions and issue price:

Price to public

Agent’s commissions and fees(1)(2)

Proceeds to us(3)

Per note

$1,000

$6.50

$993.50

Total

$5,070,000

$32,955

$5,037,045

(1)The notes will be sold only to investors purchasing the notes in fee-based advisory accounts.

(2)MS & Co. expects to sell all of the notes that it purchases from us to an unaffiliated dealer at a price of $993.50 per note, for further sale to certain fee-based advisory accounts at the price to public of $1,000 per note. MS & Co. will not receive a sales commission with respect to the notes. See “Supplemental information regarding plan of distribution; conflicts of interest.” For additional information, see “Plan of Distribution (Conflicts of Interest)” in the accompanying product supplement.

(3)See “Use of Proceeds and Hedging” in the accompanying product supplement.

The notes involve risks not associated with an investment in ordinary debt securities. See “Risk Factors” beginning on page 5.

The Securities and Exchange Commission and state securities regulators have not approved or disapproved these notes, or determined if this document or the accompanying product supplement, index supplement and prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

The notes are not deposits or savings accounts and are not insured by the Federal Deposit Insurance Corporation or any other governmental agency or instrumentality, nor are they obligations of, or guaranteed by, a bank.

You should read this document together with the related product supplement, index supplement and prospectus, each of which can be accessed via the hyperlinks below. When you read the accompanying index supplement, please note that all references in such supplement to the prospectus dated November 16, 2023, or to any sections therein, should refer instead to the accompanying prospectus dated April 12, 2024 or to the corresponding sections of such prospectus, as applicable. Please also see “Additional Terms of the Notes” and “Additional Information About the Notes” at the end of this document.

References to “we,” “us” and “our” refer to Morgan Stanley or MSFL, or Morgan Stanley and MSFL collectively, as the context requires.

Product Supplement for Notes dated February 7, 2025 Index Supplement dated November 16, 2023

Prospectus dated April 12, 2024

&nbsp;

Morgan Stanley Finance LLC

Market-Linked Notes

&nbsp;

Terms continued from the previous page

Payment at maturity per note:

If the final level is greater than the initial level:

(stated principal amount + upside payment), subject to the maximum payment at maturity

If the final level is equal to or less than the initial level:

stated principal amount

Under no circumstances will the payment at maturity be less than the stated principal amount.

Upside payment:

stated principal amount × participation rate × underlier percent change

Participation rate:

100%

Underlier percent change:

(final level – initial level) / initial level

Maximum payment at maturity:

$1,081.50 per note (108.15% of the stated principal amount)

Final level:

The closing level of the underlier on the observation date

Initial level:

6,279.35, which is the closing level of the underlier on the strike date

CUSIP:

61778NER8

ISIN:

US61778NER89

Listing:

The notes will not be listed on any securities exchange.

&nbsp;Page 2

Morgan Stanley Finance LLC

Market-Linked Notes

&nbsp;

Estimated Value of the Notes

The original issue price of each note is $1,000. This price includes costs associated with issuing, selling, structuring and hedging the notes, which are borne by you, and, consequently, the estimated value of the notes on the pricing date is less than $1,000. Our estimate of the value of the notes as determined on the pricing date is set forth on the cover of this document.

What goes into the estimated value on the pricing date?

In valuing the notes on the pricing date, we take into account that the notes comprise both a debt component and a performance-based component linked to the underlier. The estimated value of the notes is determined using our own pricing and valuation models, market inputs and assumptions relating to the underlier, instruments based on the underlier, volatility and other factors including current and expected interest rates, as well as an interest rate related to our secondary market credit spread, which is the implied interest rate at which our conventional fixed rate debt trades in the secondary market.

What determines the economic terms of the notes?

In determining the economic terms of the notes, we use an internal funding rate, which is likely to be lower than our secondary market credit spreads and therefore advantageous to us. If the issuing, selling, structuring and hedging costs borne by you were lower or if the internal funding rate were higher, one or more of the economic terms of the notes would be more favorable to you.

What is the relationship between the estimated value on the pricing date and the secondary market price of the notes?

The price at which MS & Co. purchases the notes in the secondary market, absent changes in market conditions, including those related to the underlier, may vary from, and be lower than, the estimated value on the pricing date, because the secondary market price takes into account our secondary market credit spread as well as the bid-offer spread that MS & Co. would charge in a secondary market transaction of this type and other factors. However, because the costs associated with issuing, selling, structuring and hedging the notes are not fully deducted upon issuance, to the extent that MS & Co. may buy or sell the notes in the secondary market during the amortization period specified herein, absent changes in market conditions, including those related to the underlier, and to our secondary market credit spreads, it would do so based on values higher than the estimated value. We expect that those higher values will also be reflected in your brokerage account statements.

MS & Co. may, but is not obligated to, make a market in the notes, and, if it once chooses to make a market, may cease doing so at any time.

&nbsp;Page 3

Morgan Stanley Finance LLC

Market-Linked Notes

&nbsp;

Hypothetical Examples

Hypothetical Payoff Diagram&nbsp;

The payoff diagram below illustrates the payment at maturity for a range of hypothetical performances of the underlier over the term of the notes, based on the following terms:

Stated principal amount:

$1,000 per note

Participation rate:

100%

Maximum payment at maturity:

$1,081.50 per note (108.15% of the stated principal amount)

Hypothetical Payoff Diagram

&nbsp;

Upside Scenario. If the final level is greater than the initial level, investors will receive the stated principal amount plus 100% of the appreciation of the underlier over the term of the notes, subject to the maximum payment at maturity.

oIf the underlier appreciates 5%, investors will receive $1,050 per note, or 105% of the stated principal amount.

oIf the underlier appreciates 100%, investors will receive only the maximum payment at maturity of $1,081.50 per note, or 108.15% of the stated principal amount.

Par Scenario. If the final level is equal to or less than the initial level, investors will receive the stated principal amount.

oIf the underlier depreciates 15%, investors will receive $1,000 per note.

&nbsp;Page 4

Morgan Stanley Finance LLC

Market-Linked Notes

&nbsp;

Risk Factors

This section describes the material risks relating to the notes. For further discussion of these and other risks, you should read the section entitled “Risk Factors” in the accompanying product supplement and prospectus. We also urge you to consult with your investment, legal, tax, accounting and other advisers in connection with your investment in the notes.

Risks Relating to an Investment in the Notes

The notes may not pay more than the stated principal amount at maturity. If the final level is equal to or less than the initial level, you will receive only the stated principal amount at maturity, and you will not receive a positive return on your investment.

The notes do not pay interest. Because the notes do not pay interest, if the final level is equal to or less than the initial level, you will not receive a positive return on your investment, and therefore the overall return on the notes (the effective yield to maturity) will be less than the amount that would be paid on an ordinary debt security. Accordingly, the return of only the stated principal amount at maturity will not compensate you for the effects of inflation and other factors relating to the value of money over time.

The appreciation potential of the notes is limited by the maximum payment at maturity. Where the final level is greater than the initial level, the appreciation potential of the notes is limited by the maximum payment at maturity. If the underlier appreciates over the term of the notes, under no circumstances will the payment at maturity exceed the maximum payment at maturity.

The amount payable on the notes is not linked to the value of the underlier at any time other than the observation date. The final level will be based on the closing level of the underlier on the observation date, subject to postponement for non-trading days and certain market disruption events. Even if the value of the underlier appreciates prior to the observation date but then drops by the observation date, the payment at maturity may be less than it would have been had the payment at maturity been linked to the value of the underlier prior to such drop. Although the actual value of the underlier on the stated maturity date or at other times during the term of the notes may be higher than the closing level of the underlier on the observation date, the payment at maturity will be based solely on the closing level of the underlier on the observation date.

The market price of the notes may be influenced by many unpredictable factors. Several factors, many of which are beyond our control, will influence the value of the notes in the secondary market and the price at which MS & Co. may be willing to purchase or sell the notes in the secondary market. We expect that generally the value of the underlier at any time will affect the value of the notes more than any other single factor. Other factors that may influence the value of the notes include:

othe volatility (frequency and magnitude of changes in value) of the underlier;

ointerest and yield rates in the market;

ogeopolitical conditions and economic, financial, political, regulatory or judicial events that affect the underlier or equity markets generally;

othe availability of comparable instruments;

othe composition of the underlier and changes in the component securities of the underlier;

othe time remaining until the notes mature; and

oany actual or anticipated changes in our credit ratings or credit spreads.

Some or all of these factors will influence the price that you will receive if you sell your notes prior to maturity. Generally, the longer the time remaining to maturity, the more the market price of the notes will be affected by the other factors described above. For example, you may have to sell your notes at a substantial discount from the stated principal amount if, at the time of sale, the closing level of the underlier is at, below or not sufficiently above the initial level, or if market interest rates rise.

You can review the historical closing levels of the underlier in the section of this document called “Historical Information.” You cannot predict the future performance of the underlier based on its historical performance. The value of the underlier may be, and has recently been, volatile, and we can give you no assurance that the volatility will lessen. There can be no assurance that the final level will be greater than the initial level so that you receive a payment at maturity that exceeds the stated principal amount of the notes.

The notes are subject to our credit risk, and any actual or anticipated changes to our credit ratings or credit spreads may adversely affect the market value of the notes. You are dependent on our ability to pay all amounts due on the notes, and, therefore, you are subject to our credit risk. The notes are not guaranteed by any other entity. If we default on our obligations under the notes, your investment would be at risk and you could lose some or all of your investment. As a result, the market value of the notes prior to maturity will be affected by changes in the market’s view of our creditworthiness. Any actual or anticipated decline in our credit ratings or increase in the credit spreads charged by the market for taking our credit risk is likely to adversely affect the market value of the notes.

As a finance subsidiary, MSFL has no independent operations and will have no independent assets. As a finance subsidiary, MSFL has no independent operations beyond the issuance and administration of its securities and will have no

&nbsp;Page 5

Morgan Stanley Finance LLC

Market-Linked Notes

&nbsp;

independent assets available for distributions to holders of MSFL securities if they make claims in respect of such securities in a bankruptcy, resolution or similar proceeding. Accordingly, any recoveries by such holders will be limited to those available under the related guarantee by Morgan Stanley and that guarantee will rank pari passu with all other unsecured, unsubordinated obligations of Morgan Stanley. Holders will have recourse only to a single claim against Morgan Stanley and its assets under the guarantee. Holders of securities issued by MSFL should accordingly assume that in any such proceedings they would not have any priority over and should be treated pari passu with the claims of other unsecured, unsubordinated creditors of Morgan Stanley, including holders of Morgan Stanley-issued securities.

The rate we are willing to pay for securities of this type, maturity and issuance size is likely to be lower than the rate implied by our secondary market credit spreads and advantageous to us. Both the lower rate and the inclusion of costs associated with issuing, selling, structuring and hedging the notes in the original issue price reduce the economic terms of the notes, cause the estimated value of the notes to be less than the original issue price and will adversely affect secondary market prices. Assuming no change in market conditions or any other relevant factors, the prices, if any, at which dealers, including MS & Co., may be willing to purchase the notes in secondary market transactions will likely be significantly lower than the original issue price, because secondary market prices will exclude the issuing, selling, structuring and hedging-related costs that are included in the original issue price and borne by you and because the secondary market prices will reflect our secondary market credit spreads and the bid-offer spread that any dealer would charge in a secondary market transaction of this type as well as other factors.

The inclusion of the costs of issuing, selling, structuring and hedging the notes in the original issue price and the lower rate we are willing to pay as issuer make the economic terms of the notes less favorable to you than they otherwise would be.

However, because the costs associated with issuing, selling, structuring and hedging the notes are not fully deducted upon issuance, to the extent that MS & Co. may buy or sell the notes in the secondary market during the amortization period specified herein, absent changes in market conditions, including those related to the underlier, and to our secondary market credit spreads, it would do so based on values higher than the estimated value, and we expect that those higher values will also be reflected in your brokerage account statements.

The estimated value of the notes is determined by reference to our pricing and valuation models, which may differ from those of other dealers and is not a maximum or minimum secondary market price. These pricing and valuation models are proprietary and rely in part on subjective views of certain market inputs and certain assumptions about future events, which may prove to be incorrect. As a result, because there is no market-standard way to value these types of securities, our models may yield a higher estimated value of the notes than those generated by others, including other dealers in the market, if they attempted to value the notes. In addition, the estimated value on the pricing date does not represent a minimum or maximum price at which dealers, including MS & Co., would be willing to purchase your notes in the secondary market (if any exists) at any time. The value of your notes at any time after the date of this document will vary based on many factors that cannot be predicted with accuracy, including our creditworthiness and changes in market conditions. See also “The market price of the notes may be influenced by many unpredictable factors” above.

The notes will not be listed on any securities exchange and secondary trading may be limited. The notes will not be listed on any securities exchange. Therefore, there may be little or no secondary market for the notes. MS & Co. may, but is not obligated to, make a market in the notes and, if it once chooses to make a market, may cease doing so at any time. When it does make a market, it will generally do so for transactions of routine secondary market size at prices based on its estimate of the current value of the notes, taking into account its bid/offer spread, our credit spreads, market volatility, the notional size of the proposed sale, the cost of unwinding any related hedging positions, the time remaining to maturity and the likelihood that it will be able to resell the notes. Even if there is a secondary market, it may not provide enough liquidity to allow you to trade or sell the notes easily. Since other broker-dealers may not participate significantly in the secondary market for the notes, the price at which you may be able to trade your notes is likely to depend on the price, if any, at which MS & Co. is willing to transact. If, at any time, MS & Co. were to cease making a market in the notes, it is likely that there would be no secondary market for the notes. Accordingly, you should be willing to hold your notes to maturity.

As discussed in more detail in the accompanying product supplement, investing in the notes is not equivalent to investing in the underlier(s).

You may be required to recognize taxable income on the notes prior to maturity. If you are a U.S. investor in a note, under the treatment of a note as a contingent payment debt instrument, you will generally be required to recognize taxable interest income in each year that you hold the note. In addition, any gain you recognize under the rules applicable to contingent payment debt instruments will generally be treated as ordinary interest income rather than capital gain. You should review carefully the section entitled “United States Federal Income Tax Considerations” herein, in combination with the section entitled “United States Federal Income Tax Considerations” in the accompanying product supplement, and consult your tax adviser regarding the U.S. federal income tax consequences of an investment in the notes.

&nbsp;Page 6

Morgan Stanley Finance LLC

Market-Linked Notes

&nbsp;

Risks Relating to the Underlier(s)

Because your return on the notes will depend upon the performance of the underlier(s), the notes are subject to the following risk(s), as discussed in more detail in the accompanying product supplement.

oAdjustments to an underlying index could adversely affect the value of the notes.

Risks Relating to Conflicts of Interest

In engaging in certain activities described below and as discussed in more detail in the accompanying product supplement, our affiliates may take actions that may adversely affect the value of and your return on the notes, and in so doing they will have no obligation to consider your interests as an investor in the notes.

The calculation agent, which is a subsidiary of Morgan Stanley and an affiliate of MSFL, will make determinations with respect to the notes. As calculation agent, MS & Co. will make any determinations necessary to calculate any payment(s) on the notes. Moreover, certain determinations made by MS & Co., in its capacity as calculation agent, may require it to exercise discretion and make subjective judgments, which may adversely affect your return on the notes. In addition, MS & Co. has determined the estimated value of the notes on the pricing date.

Hedging and trading activity by our affiliates could potentially adversely affect the value of the notes.

&nbsp;Page 7

Morgan Stanley Finance LLC

Market-Linked Notes

&nbsp;

Historical Information

S&P 500® Index Overview

Bloomberg Ticker Symbol: SPX

The S&P 500® Index is intended to provide a benchmark for performance measurement of the large capitalization segment of the U.S. equity markets by tracking the stock price movement of 500 companies with large market capitalizations. The underlying index publisher with respect to the S&P 500® Index is S&P® Dow Jones Indices LLC, or any successor thereof. Component stocks of the S&P 500® Index are required to have a total company level market capitalization that reflects approximately the 85th percentile of the S&P® Total Market Index. The S&P 500® Index measures the relative performance of the common stocks of 500 companies as of a particular time as compared to the performance of the common stocks of 500 similar companies during the base period of the years 1941 through 1943. For additional information about the S&P 500® Index, see the information set forth under “S&P® U.S. Indices—S&P 500® Index” in the accompanying index supplement.

The closing level of the underlier on July 3, 2025 was 6,279.35. The following graph sets forth the daily closing levels of the underlier for the period noted below. We obtained the historical information presented in this document from Bloomberg Financial Markets, without independent verification. The underlier has at times experienced periods of high volatility. You should not take the historical closing levels of the underlier as an indication of its future performance, and no assurance can be given as to the closing level of the underlier at any time.

Underlier Daily Closing Levels

January 1, 2020 to July 3, 2025

&nbsp;

&nbsp;

&nbsp;Page 8

Morgan Stanley Finance LLC

Market-Linked Notes

&nbsp;

Additional Terms of the Notes

Please read this information in conjunction with the terms on the cover of this document.

Additional Terms:

If the terms described herein are inconsistent with those described in the accompanying product supplement, index supplement or prospectus, the terms described herein shall control.

Denominations:

$1,000 per note and integral multiples thereof

Amortization period:

The 6-month period following the issue date

Trustee:

The Bank of New York Mellon

Calculation agent:

Morgan Stanley & Co. LLC (“MS & Co.”)

&nbsp;Page 9

Morgan Stanley Finance LLC

Market-Linked Notes

&nbsp;

Additional Information About the Notes

Additional Information:

Minimum ticketing size:

$1,000 / 1 note

United States federal income tax considerations:

You should review carefully the section in the accompanying product supplement entitled “United States Federal Income Tax Considerations.” The following discussion, when read in combination with that section, constitutes the full opinion of our counsel, Davis Polk & Wardwell LLP, regarding the material U.S. federal income tax consequences of owning and disposing of the notes.

Generally, this discussion assumes that you purchased the notes for cash in the original issuance at the stated issue price and does not address other circumstances specific to you, including consequences that may arise due to any other investments relating to an underlier. You should consult your tax adviser regarding the effect any such circumstances may have on the U.S. federal income tax consequences of your ownership of a note.

The notes should be treated as debt instruments for U.S. federal income tax purposes. Based on current market conditions, we intend to treat the notes for U.S. federal income tax purposes as contingent payment debt instruments, or “CPDIs,” as described in “United States Federal Income Tax Considerations—Tax Consequences to U.S. Holders—Notes Treated as Contingent Payment Debt Instruments” in the accompanying product supplement.  Under this treatment, regardless of your method of accounting for U.S. federal income tax purposes, you generally will be required to accrue interest income in each year on a constant yield to maturity basis at the “comparable yield,” as determined by us, adjusted upward or downward to reflect the difference, if any, between the actual and projected payments on the notes during the year. Upon a taxable disposition of a note, you generally will recognize taxable income or loss equal to the difference between the amount received and your tax basis in the notes. You generally must treat any income realized as interest income and any loss as ordinary loss to the extent of previous interest inclusions, and the balance as capital loss, the deductibility of which is subject to limitations.

We have determined that the comparable yield for a note is a rate of 4.1180% per annum, compounded semi-annually. Based upon our determination of the comparable yield and assuming a semi-annual accrual period, the following table sets out the “projected payment schedule” per $1,000 principal amount of note, as well as the amount of taxable interest income (without taking into account any adjustment to reflect the difference, if any, between the actual and the projected amount of the contingent payment on a note) that will be deemed to have accrued with respect to a note during each calendar period.

Projected Payment Date(s)

Projected Payment(s) (per $1,000)

Accrued OID During Calendar Period (per $1,000)

Total Accrued OID (per $1,000)

December 30, 2025

$0.0000

$19.5605

$19.5605

June 30, 2026

$0.0000

$20.9928

$40.5533

December 30, 2026

$0.0000

$21.4250

$61.9783

January 7, 2027

$1,062.8286

$0.8503

$62.8286

Neither the comparable yield nor the projected payment schedule constitutes a representation by us regarding the actual amount(s) that we will pay on the notes.

Non-U.S. Holders. If you are a Non-U.S. Holder, please also read the section entitled “United States Federal Income Tax Considerations—Tax Consequences to Non-U.S. Holders” in the accompanying product supplement.

As discussed under “United States Federal Income Tax Considerations—Tax Consequences to Non-U.S. Holders—Dividend Equivalents under Section 871(m) of the Code” in the accompanying product supplement, Section 871(m) of the Internal Revenue Code and Treasury regulations promulgated thereunder (“Section 871(m)”) generally impose a 30% withholding tax on dividend equivalents paid or deemed paid to Non-U.S. Holders with respect to certain financial instruments linked to U.S. equities or indices that include U.S. equities. The Treasury regulations, as modified by an IRS notice, exempt financial instruments issued prior to January 1, 2027 that do not have a “delta” of one. Based on certain representations made by us, our counsel is of the opinion that Section 871(m) should not apply to the notes with respect to Non-U.S. Holders. Our determination is not binding on the IRS, and the IRS may disagree with this determination.

We will not be required to pay any additional amounts with respect to U.S. federal withholding taxes.

You should consult your tax adviser regarding the U.S. federal income tax consequences of an investment in the notes, as well as tax consequences arising under the laws of any state, local or non-U.S. taxing jurisdiction.

&nbsp;Page 10

Morgan Stanley Finance LLC

Market-Linked Notes

&nbsp;

Additional considerations:

Client accounts over which Morgan Stanley, Morgan Stanley Wealth Management or any of their respective subsidiaries have investment discretion are not permitted to purchase the notes, either directly or indirectly.

Supplemental information regarding plan of distribution; conflicts of interest:

MS & Co. expects to sell all of the notes that it purchases from us to an unaffiliated dealer at a price of $993.50 per note, for further sale to certain fee-based advisory accounts at the price to public of $1,000 per note. MS & Co. will not receive a sales commission with respect to the notes.

MS & Co. is an affiliate of MSFL and a wholly owned subsidiary of Morgan Stanley, and it and other affiliates of ours expect to make a profit by selling, structuring and, when applicable, hedging the notes.

MS & Co. will conduct this offering in compliance with the requirements of FINRA Rule 5121 of the Financial Industry Regulatory Authority, Inc., which is commonly referred to as FINRA, regarding a FINRA member firm’s distribution of the securities of an affiliate and related conflicts of interest. MS & Co. or any of our other affiliates may not make sales in this offering to any discretionary account. See “Plan of Distribution (Conflicts of Interest)” and “Use of Proceeds and Hedging” in the accompanying product supplement.

Validity of the notes:

In the opinion of Davis Polk & Wardwell LLP, as special counsel to MSFL and Morgan Stanley, when the notes offered by this pricing supplement have been executed and issued by MSFL, authenticated by the trustee pursuant to the MSFL Senior Debt Indenture (as defined in the accompanying prospectus) and delivered against payment as contemplated herein, such notes will be valid and binding obligations of MSFL and the related guarantee will be a valid and binding obligation of Morgan Stanley, enforceable in accordance with their terms, subject to applicable bankruptcy, insolvency and similar laws affecting creditors’ rights generally, concepts of reasonableness and equitable principles of general applicability (including, without limitation, concepts of good faith, fair dealing and the lack of bad faith), provided that such counsel expresses no opinion as to (i) the effect of fraudulent conveyance, fraudulent transfer or similar provision of applicable law on the conclusions expressed above and (ii) any provision of the MSFL Senior Debt Indenture that purports to avoid the effect of fraudulent conveyance, fraudulent transfer or similar provision of applicable law by limiting the amount of Morgan Stanley’s obligation under the related guarantee. This opinion is given as of the date hereof and is limited to the laws of the State of New York, the General Corporation Law of the State of Delaware and the Delaware Limited Liability Company Act. In addition, this opinion is subject to customary assumptions about the trustee’s authorization, execution and delivery of the MSFL Senior Debt Indenture and its authentication of the notes and the validity, binding nature and enforceability of the MSFL Senior Debt Indenture with respect to the trustee, all as stated in the letter of such counsel dated February 26, 2024, which is Exhibit 5-a to Post-Effective Amendment No. 2 to the Registration Statement on Form S-3 filed by Morgan Stanley on February 26, 2024.

Where you can find more information:

Morgan Stanley and MSFL have filed a registration statement (including a prospectus, as supplemented by the product supplement and the index supplement) with the Securities and Exchange Commission (the “SEC”) for the offering to which this communication relates. You should read the prospectus in that registration statement, the product supplement, the index supplement and any other documents relating to this offering that MSFL and Morgan Stanley have filed with the SEC for more complete information about Morgan Stanley and this offering. When you read the accompanying index supplement, please note that all references in such supplement to the prospectus dated November 16, 2023, or to any sections therein, should refer instead to the accompanying prospectus dated April 12, 2024 or to the corresponding sections of such prospectus, as applicable. You may get these documents without cost by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, MSFL, Morgan Stanley, any underwriter or any dealer participating in the offering will arrange to send you the prospectus, the index supplement and the product supplement if you so request by calling toll-free 1-(800)-584-6837.

Terms used but not defined in this document are defined in the product supplement, in the index supplement or in the prospectus. Each of the product supplement, the index supplement and the prospectus can be accessed via the hyperlinks set forth on the cover of this document.

&nbsp;

&nbsp;Page 11

FAQ

What is the maximum return on Morgan Stanley’s S&P 500 Market-Linked Notes (MS)?

The maximum payment at maturity is $1,081.50 per $1,000 note, equal to an 8.15 % total return.

Do the notes pay periodic interest or coupons?

No. The notes are zero-coupon; investors receive payment only at maturity.

How is investor principal protected?

At maturity investors receive no less than the $1,000 face amount, provided Morgan Stanley meets its obligations.

What is the estimated value versus issue price?

Morgan Stanley’s model-based estimated value on the pricing date is $985, approximately 1.5 % below the $1,000 issue price.

Can the notes be sold before maturity?

The notes are not exchange-listed. Morgan Stanley & Co. may provide a secondary market but is not obligated to do so.

What are the key tax considerations for U.S. investors?

The notes are expected to be treated as contingent payment debt instruments; holders must accrue OID income annually at a comparable yield of 4.118 %.

Is the issuance material to Morgan Stanley’s financials?

No. The aggregate principal amount is $5.07 million, immaterial relative to Morgan Stanley’s overall funding and earnings.
Morgan Stanley

NYSE:MS

MS Rankings

MS Latest News

MS Latest SEC Filings

MS Stock Data

228.66B
1.22B
23.64%
62.12%
0.89%
Capital Markets
Security Brokers, Dealers & Flotation Companies
Link
United States
NEW YORK